loader
Please Wait
Applying Filters...

Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

List of Certificates of Suitability (CEPs) for cep_2022_213___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 IPCA LABORATORIES LIMITED Mumbai IN (1)

filter

01 Famotidine, FM3 Process (1)

filter

01 India (1)

filter

01 Valid (1)

URL Supplier Web Content
CEP 2022-213 - Rev 01
Valid
Chemical
2023-10-19
1012
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for CEP 2022-213 - Rev 01 of Ipca Laboratories Limited Mumbai In

Looking for Certificates of Suitability (CEPs) for CEP 2022-213 - Rev 01 of Ipca Laboratories Limited Mumbai In 1

20

Ipca Laboratories Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their significant offerings is Famotidine, FM3 Process, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2022-213 - Rev 01

This Chemical Type CEP, issued on October 19, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 1012 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY